Medical Device and Healthcare Industry Trends — 2026-06-11

Top 5 Headlines of the Day

• South Korean Aesthetic Medical Device Market: A $2B market where companies like Classys, Wontech, and Jeisys are building high-margin export machinery using HIFU and RF technology.
• Samsung Medison Enters U.S. Market: Supplied premium ultrasound diagnostic systems to two major U.S. medical institutions.
• Accelerating AI Medical Device Regulations: The South Korean MFDS is continuously expanding its licensing, certification, and reporting system for AI-based SaMD and medical devices.
• FDA Eases Wearable/AI Regulations: The U.S. FDA reduced regulations on low-risk AI clinical decision support software and wearables (January 2026).
• Global AI Medical Device Market: Expected CAGR growth from 2026 to 2035, accelerated by clinical workforce shortages and the demand for algorithm validation.

Key Corporate Trends

Samsung Medison — Supply Contract with U.S. Medical Institutions

• What's happening: Samsung's subsidiary, Samsung Medison, signed a supply contract to provide premium ultrasound diagnostic systems to two leading U.S. medical institutions.
• Implication: This serves as an example of how Samsung's medical device division is consistently strengthening its position in the global ultrasound market and how demand from major U.S. hospitals is reconfirming the technical prowess of South Korean medical devices.

1 sources

mk.co.kr

mk.co.kr

Classys — Q1 Revenue of 8.72 Billion KRW, 42.7% Operating Profit Margin

• What's happening: Q1 revenue reached 8.72 billion KRW (+13% year-over-year), reflecting the acquisition of Brazilian distributor MedSystems.
• Numbers: Achieved a 42.7% operating profit margin and strengthened its position in the South American market through distribution diversification.
• Implication: Aesthetic medical device companies based on HIFU/RF are securing global distribution networks through M&A, which is one of the reasons for high PE interest.

MFDS, Policy, and Regulation

Expansion of AI Medical Device Approval Guidelines

• Content: The MFDS is clarifying approval standards and strengthening expedited review pathways for AI-based Software as a Medical Device (SaMD) and Digital Therapeutics (DTx).
• Target: AI-based diagnosis, prediction, and treatment software, and wearable healthcare devices.
• Industry Impact: Provides a foundation for domestic AI medical device startups like Lunit, VUNO, and MediGene AI to shorten approval paths and expand globally.

1 sources

static.wixstatic.com

static.wixstatic.com

Repeal of 'Grace Period' for Medical Device GMP Regular Inspections (Announced March 26)

• Content: When the GMP expiration date for In Vitro Diagnostic (IVD) medical devices occurs, manufacturing and import sales are immediately prohibited without any grace period.
• Target: All IVD manufacturers.
• Industry Impact: Stricter management of GMP renewal schedules increases compliance costs for manufacturers, making prior preparation essential.

1 sources

hitnews.co.kr

hitnews.co.kr

Digital Health & AI Medicine

• FDA Wearable/AI Regulation Easing (January 2026): Reduced FDA regulations on low-risk Clinical Decision Support (CDS) software and non-invasive wearables. Access to the U.S. market has improved for South Korean smart band and health monitoring app companies.

• FDA TEMPO Pilot Program: Introduction of a risk-based enforcement approach for digital health devices, allowing for early market entry of chronic disease monitoring devices and parallel FDA review processes.

• Global AI Medical Device Market Forecast: CAGR growth expected from 2026 to 2035 due to clinical labor shortages and demand for algorithm validation. Strengthening competitiveness for South Korean imaging diagnosis AI (Lunit, VUNO) and digital health platforms for metabolic disease monitoring.

Global MedTech Context

• FDA Regulatory Easing Trend: Reduced regulations on low-risk AI and wearables are cutting time and costs for South Korean firms entering the U.S., particularly for companies specializing in smart bands, remote monitoring platforms, and digital therapeutics.

• Expansion of Global AI Medical Device Market: Rapid surge in demand for AI diagnosis and decision support due to clinical labor shortages. South Korean AI for image diagnosis and clinical data analysis software are strengthening their competitiveness in U.S. and European markets.

Investment, M&A, and IPO Trends

No new investments or M&A activities currently reported.

Today's Insight

The South Korean medical device industry is driving global growth through a two-pronged strategy. One is the activation of M&A, with aesthetic device companies like Classys securing South American and Asian distribution networks through PE firms. The other is MFDS's regulatory innovation for AI medical devices, allowing startups like Lunit and VUNO to enter the U.S. market rapidly amidst the FDA's regulatory easing. In particular, as the FDA has reduced regulations on low-risk AI and wearables, the barrier for South Korean digital health and AI technology to enter the U.S. market has been lowered significantly.

Weekly Checkpoints

• Check the latest MFDS announcements on AI medical device approval guidelines.
• Look for additional M&A news regarding aesthetic device companies like Classys.
• Track U.S. FDA approval schedules for AI diagnostic device companies like Lunit and VUNO.

Reader Action Items

• Medical Device Manufacturers: Immediately check the GMP renewal schedule for in vitro diagnostic devices to prepare for the repeal of the grace period.
• AI Medical Device Startups: Re-read the U.S. FDA's 2026 guidance on wearable/AI CDS to leverage opportunities for shortened regulatory pathways.
• Investors: Track the IPO and M&A pipelines for high-margin aesthetic medical device companies like Classys and AI diagnostic startups.